Precigen Inc 's ability to collect accounts receivable sequentially worsen to 3.86, indicating more challenging environment then in the fourth quarter 2025, but still, it is a far cry from any concerns. Precigen Inc 's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 95 days, from 67 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 418 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2779, from overall ranking in the fourth quarter 2025 at 3003.

What is Receivable Turnover Ratio?
What is Precigen Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PGEN Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	2409.87 %	275.06 %	50.89 %	-43.8 %	-8.43 %
Y / Y Revenue Change	1633.93 %	-	206.61 %	19.39 %	25.92 %
Receivable Turnover Ratio (TTM)	3.86	5.46	5.25	3.57	3.03
PGEN's Total Ranking	# 2779	# 3003	# 0	# 0	# 0
Accounts Receivable average collection period days	95	67	69	102	120
Seq. Receivable Change	512.22 %	296.55 %	92.64 %	-46.33 %	-8.51 %
Seq. Revenue Change	409.35 %	56.23 %	241.36 %	-36.17 %	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 131
Healthcare Sector	# 419
Overall Market	# 2779

Receivable Turnover Ratio Statistics
High	Average	Low
18.91	3.6	-1.95
(Mar 31 2021)		(Sep 30 2024)

PGEN Company Profile • Back to PGEN Efficiency Comparisons • Compare PGEN Receivables Turnover Ratio to its Competitors

Financial Statements
Precigen Inc 's Accounts Receivable	$ 27 Millions	Visit PGEN's Balance sheet
Precigen Inc 's Sales TTM	$ 32 Millions	Visit PGEN's Income Statement
Sources of PGEN's Revenues		Visit PGEN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PGEN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PGEN's Growth Rates	PGEN's Roa	PGEN's Inventory Turnover Ratio	PGEN's Dividend Comparisons
PGEN's Profitability Ratios	PGEN's Roi	PGEN's Asset Turnover Ratio	PGEN's Dividend Growth
PGEN's Valuation Ratios	PGEN's Roe	PGEN's Financial Strength Ratios	PGEN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Axsome Therapeutics Inc	3.25	$ 708.236 Millions	$ 217.715 Millions
Recursion Pharmaceuticals Inc	3.25	$ 66.408 Millions	$ 20.438 Millions
Arcutis Biotherapeutics Inc	3.24	$ 415.624 Millions	$ 128.103 Millions
Apellis Pharmaceuticals Inc	3.24	$ 1,105.280 Millions	$ 341.547 Millions
Cumberland Pharmaceuticals Inc	3.23	$ 41.940 Millions	$ 12.989 Millions
Tenon Medical Inc	3.20	$ 4.597 Millions	$ 1.437 Millions
Keenova Therapeutics Plc	3.12	$ 1,413.000 Millions	$ 453.200 Millions
Establishment Labs Holdings Inc	3.09	$ 228.835 Millions	$ 74.027 Millions
Phathom Pharmaceuticals Inc	3.08	$ 204.892 Millions	$ 66.474 Millions
Cormedix Inc	2.96	$ 389.749 Millions	$ 131.881 Millions
Journey Medical Corp	2.93	$ 64.680 Millions	$ 22.101 Millions
Harrow Inc	2.90	$ 267.575 Millions	$ 92.144 Millions
Sensus Healthcare Inc	2.90	$ 22.907 Millions	$ 7.894 Millions
Adc Therapeutics Sa	2.90	$ 79.175 Millions	$ 27.316 Millions
Docgo Inc	2.90	$ 301.713 Millions	$ 104.158 Millions
Cartesian Therapeutics Inc	2.90	$ 1.775 Millions	$ 0.613 Millions
Seer Inc	2.88	$ 14.386 Millions	$ 5.004 Millions
Allurion Technologies Inc	2.86	$ 12.357 Millions	$ 4.314 Millions
Anteris Technologies Global Corp	2.80	$ 1.851 Millions	$ 0.660 Millions
Astrotech Corp	2.73	$ 1.008 Millions	$ 0.369 Millions
Electromed Inc	2.73	$ 70.478 Millions	$ 25.841 Millions
Autolus Therapeutics Plc	2.68	$ 92.624 Millions	$ 34.624 Millions
Regeneron Pharmaceuticals Inc	2.62	$ 14,919.600 Millions	$ 5,692.300 Millions
Marker Therapeutics inc	2.60	$ 3.949 Millions	$ 1.522 Millions
Fennec Pharmaceuticals Inc	2.59	$ 50.999 Millions	$ 19.707 Millions
Brightspring Health Services Inc	2.54	$ 2,595.630 Millions	$ 1,022.222 Millions
Aclarion Inc	2.53	$ 0.078 Millions	$ 0.031 Millions
Profound Medical Corp	2.39	$ 18.814 Millions	$ 7.880 Millions
Tg Therapeutics Inc	2.35	$ 700.349 Millions	$ 298.644 Millions
American Shared Hospital Services	2.32	$ 28.410 Millions	$ 12.260 Millions

Date modified: 2026-08-30T14:44:48+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.